CoChat
Sign Up
Cited by 291

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease

Zhao, Wei-Qin, Townsend, Matthew·2009·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
DOI 10.1016/j.bbadis.2008.10.014
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbadis.2008.10.014

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Recent studies implicate BACE1 in alterations in insulin and leptin signaling, presenting BACE1 action as a potential link between AD and T2D.

    “Recent studies implicate BACE1 in alterations in insulin and leptin signaling, presenting BACE1 action as a potential link between AD and T2D.”

    From BACE1: More than just a β‐secretase (2022) · cites this paper as [83]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 308

  1. Kodl, 2008, Cognitive dysfunction and diabetes mellitus 1, Endocr. Rev., 29, 494, 10.1210/er.2007-0034 · DOI
  2. Perlmuter, 1984, Decreased cognitive function in aging non-insulin-dependent diabetic patients, Am. J. Med., 77, 1043, 10.1016/0002-9343(84)90186-4 · DOI
  3. Haan, 2006, Therapy Insight: type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease, Nat. Clin. Pract. Neurol., 2, 159, 10.1038/ncpneuro0124 · DOI · Paper page
  4. Ott, 1999, Diabetes mellitus and the risk of dementia: the Rotterdam Study, Neurology, 53, 1937, 10.1212/WNL.53.9.1937 · DOI · Paper page
  5. Skoog, 1996, 15-year longitudinal study of blood pressure and dementia, Lancet, 347, 1141, 10.1016/S0140-6736(96)90608-X · DOI · Paper page
  6. Leibson, 1997, Relative contributions of incidence and survival to increasing prevalence of adult-onset diabetes mellitus: a population-based study, Am. J. Epidemiol., 146, 12, 10.1093/oxfordjournals.aje.a009187 · DOI
  7. Stolk, 1997, Diabetes mellitus, impaired glucose tolerance, and hyperinsulinemia in an elderly population. The Rotterdam Study, Am. J. Epidemiol., 145, 24, 10.1093/oxfordjournals.aje.a009028 · DOI
  8. Stolk, 1997, Insulin and cognitive function in an elderly population. The Rotterdam Study, Diabetes Care, 20, 792, 10.2337/diacare.20.5.792 · DOI
  9. Kilander, 1998, Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men, Hypertension, 31, 780, 10.1161/01.HYP.31.3.780 · DOI · Paper page
  10. Grant, 1999, Dietary links to Alzheimer's disease: 1999 update, J. Alzheimer’s Dis., 1, 197, 10.3233/JAD-1999-14-501 · DOI
  11. Myers, 2000, Susceptibility locus for Alzheimer's disease on chromosome 10, Science, 290, 2304, 10.1126/science.290.5500.2304 · DOI
  12. Petot, 2003, Interactions of apolipoprotein E genotype and dietary fat intake of healthy older persons during mid-adult life, Metabolism, 52, 279, 10.1053/meta.2003.50066 · DOI
  13. Hoyer, 1998, Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis, J. Neural Transm., 105, 415, 10.1007/s007020050067 · DOI
  14. Hoyer, 2000, Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease. Causes and consequences: an update, Exp. Gerontol., 35, 1363, 10.1016/S0531-5565(00)00156-X · DOI
  15. Hoyer, 2002, The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update, J. Neural Transm., 109, 341, 10.1007/s007020200028 · DOI
  16. Watson, 2006, Insulin resistance, inflammation, and cognition in Alzheimer's Disease: lessons for multiple sclerosis, J. Neurol. Sci., 245, 21, 10.1016/j.jns.2005.08.017 · DOI
  17. Cole, 2007, The role of insulin and neurotrophic factor signaling in brain aging and Alzheimer's Disease, Exp. Gerontol., 42, 10, 10.1016/j.exger.2006.08.009 · DOI
  18. de la Monte, 2006, Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease, J. Alzheimer’s Dis., 10, 89, 10.3233/JAD-2006-10113 · DOI
  19. de la Monte, 2005, Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease, J. Alzheimer’s Dis., 7, 45, 10.3233/JAD-2005-7106 · DOI
  20. Hoyer, 1990, Brain glucose and energy metabolism during normal aging, Aging (Milano), 2, 245
  21. Magistretti, 2006, Neuron-glia metabolic coupling and plasticity, J. Exp. Biol., 209, 2304, 10.1242/jeb.02208 · DOI
  22. Dunne, 2004, Hyperinsulinism in infancy: from basic science to clinical disease, Physiol. Rev., 84, 239, 10.1152/physrev.00022.2003 · DOI
  23. Richardson, 1990, Cognitive function in diabetes-mellitus, Neurosci. Biobehav. Rev., 14, 385, 10.1016/S0149-7634(05)80060-0 · DOI · Paper page
  24. Tun, 1990, Cognitive and affective disorders in elderly diabetics, Clin. Geriatr. Med., 6, 731, 10.1016/S0749-0690(18)30578-0 · DOI
  25. Helkala, 1995, Short-term and long-term memory in elderly patients with NIDDM, Diabetes Care, 18, 681, 10.2337/diacare.18.5.681 · DOI
  26. de Weid, 1975, Memory deficit in rats with hereditary diabetes insipidus, Brain Res., 85, 152, 10.1016/0006-8993(75)91022-7 · DOI
  27. Biessels, 1996, Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats, Diabetes, 45, 1259, 10.2337/diab.45.9.1259 · DOI
  28. McNay, 2004, Effect of recurrent hypoglycemia on spatial cognition and cognitive metabolism in normal and diabetic rats, Diabetes, 53, 418, 10.2337/diabetes.53.2.418 · DOI
  29. McNay, 2006, Cognitive and neural hippocampal effects of long-term moderate recurrent hypoglycemia, Diabetes, 55, 1088, 10.2337/diabetes.55.04.06.db05-1314 · DOI
  30. Dou, 2005, Insulin receptor signaling in long-term memory consolidation following spatial learning, Learn. Mem., 12, 646, 10.1101/lm.88005 · DOI
  31. Moreira, 2007, Diabetic type II Goto-Kakizaki rats show progressively decreasing exploratory activity and learning impairments in fixed and progressive ratios of a lever-press task, Behav. Brain Res., 180, 28, 10.1016/j.bbr.2007.02.034 · DOI
  32. Li, 2007, Alzheimer-like changes in rat models of spontaneous diabetes, Diabetes, 56, 1817, 10.2337/db07-0171 · DOI
  33. Stranahan, 2008, Impact of Energy Intake and Expenditure on Neuronal Plasticity, Neuromol. Med., 10.1007/s12017-008-8043-0 · DOI
  34. Stranahan, 2008, Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons, Nat. Neurosci., 11, 309, 10.1038/nn2055 · DOI
  35. Minoshima, 1994, Stereotactic PET atlas of the human brain: aid for visual interpretation of functional brain images, J. Nucl. Med., 35, 949
  36. Reiman, 2001, Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: a foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease, Proc. Natl. Acad. Sci. U. S. A., 98, 3334, 10.1073/pnas.061509598 · DOI · Paper page
  37. Small, 1995, Predictors of cognitive change in middle-aged and older adults with memory loss, Am. J. Psychiatry, 152, 1757, 10.1176/ajp.152.12.1757 · DOI
  38. Small, 2000, Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease, Proc. Natl. Acad. Sci. U. S. A., 97, 6037, 10.1073/pnas.090106797 · DOI · Paper page
  39. de Leon, 2001, Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-d-glucose/poitron-emission tomography (FDG/PET)40, Proc. Natl. Acad. Sci. U. S. A., 98, 10966, 10.1073/pnas.191044198 · DOI · Paper page
  40. Foster, 1984, Cortical abnormalities in Alzheimer's disease, Ann. Neurol., 16, 649, 10.1002/ana.410160605 · DOI
  41. Friedland, 1985, Alzheimer's disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization, Neurosci. Lett., 53, 235, 10.1016/0304-3940(85)90543-9 · DOI
  42. Koss, 1985, Differences in lateral hemispheric asymmetries of glucose utilization between early- and late-onset Alzheimer-type dementia, Am. J. Psychiatry, 142, 638, 10.1176/ajp.142.5.638 · DOI
  43. Mosconi, 2008, Hippocampal hypometabolism predicts cognitive decline from normal aging, Neurobiol. Aging, 29, 676, 10.1016/j.neurobiolaging.2006.12.008 · DOI · Paper page
  44. Mosconi, 2004, MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET, Neurology, 63, 2332, 10.1212/01.WNL.0000147469.18313.3B · DOI
  45. Mosconi, 2008, Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias, J. Nucl. Med., 49, 390, 10.2967/jnumed.107.045385 · DOI · Paper page
  46. Reiman, 2004, Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia, Proc. Natl. Acad. Sci. U. S. A., 101, 284, 10.1073/pnas.2635903100 · DOI · Paper page
  47. Pettegrew, 1994, Alterations of cerebral metabolism in probable Alzheimer's disease: a preliminary study, Neurobiol. Aging, 15, 117, 10.1016/0197-4580(94)90152-X · DOI
  48. Kennedy, 1995, Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease, Neurosci. Lett., 186, 17, 10.1016/0304-3940(95)11270-7 · DOI · Paper page
  49. Valla, 2008, FDG autoradiography reveals developmental and pathological effects of mutant amyloid in PDAPP transgenic mice, Int. J. Dev. Neurosci., 26, 253, 10.1016/j.ijdevneu.2008.02.003 · DOI
  50. Needham, 2008, Identification of the Alzheimer's disease amyloid precursor protein (APP) and its homologue APLP2 as essential modulators of glucose and insulin homeostasis and growth, J. Pathol., 215, 155, 10.1002/path.2343 · DOI
  51. Hsiao, 1996, Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice, Science, 274, 99, 10.1126/science.274.5284.99 · DOI · Paper page
  52. Ashe, 2000, Synaptic structure and function in transgenic APP mice, Ann. N.Y. Acad. Sci., 924, 39, 10.1111/j.1749-6632.2000.tb05558.x · DOI
  53. Bigl, 2003, Cortical glucose metabolism is altered in aged transgenic Tg2576 mice that demonstrate Alzheimer plaque pathology, J. Neural Transm., 110, 77, 10.1007/s00702-002-0772-x · DOI
  54. Choeiri, 2002, Immunohistochemical localization and quantification of glucose transporters in the mouse brain, Neuroscience, 111, 19, 10.1016/S0306-4522(01)00619-4 · DOI
  55. Hooijmans, 2007, Amyloid beta deposition is related to decreased glucose transporter-1 levels and hippocampal atrophy in brains of aged APP/PS1 mice, Brain Res., 1181, 93, 10.1016/j.brainres.2007.08.063 · DOI
  56. Bell, 1991, Lilly lecture 1990. Molecular defects in diabetes mellitus, Diabetes, 40, 413, 10.2337/diab.40.4.413 · DOI
  57. Taylor, 1992, Lilly Lecture: molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin-receptor gene, Diabetes, 41, 1473, 10.2337/diab.41.11.1473 · DOI
  58. Le Roith, 2001, Recent advances in our understanding of insulin action and insulin resistance, Diabetes Care, 24, 588, 10.2337/diacare.24.3.588 · DOI
  59. Heidenreich, 1983, Structural differences between insulin receptors in the brain and peripheral target tissues, J. Biol. Chem., 258, 8527, 10.1016/S0021-9258(18)32085-4 · DOI
  60. Kuusisto, 1993, Essential hypertension and cognitive function. The role of hyperinsulinemia, Hypertension, 22, 771, 10.1161/01.HYP.22.5.771 · DOI
  61. Kalmijn, 1995, Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men, Diabetologia, 38, 1096, 10.1007/BF00402181 · DOI
  62. Frolich, 1999, A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer's disease, Ann. N.Y. Acad. Sci., 893, 290, 10.1111/j.1749-6632.1999.tb07839.x · DOI
  63. Steen, 2005, Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease–is this type 3 diabetes?, J. Alzheimer’s Dis., 7, 63, 10.3233/JAD-2005-7107 · DOI · Paper page
  64. Craft, 1998, Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype, Neurology, 50, 164, 10.1212/WNL.50.1.164 · DOI · Paper page
  65. Pedersen, 2006, Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice, Exp. Neurol., 199, 265, 10.1016/j.expneurol.2006.01.018 · DOI
  66. Watson, 2005, Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study, Am. J. Geriatr. Psychiatry, 13, 950
  67. Ho, 2004, Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease, FASEB J., 18, 902, 10.1096/fj.03-0978fje · DOI
  68. Wang, 2005, Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease, FASEB J., 19, 659, 10.1096/fj.04-3182fje · DOI
  69. Lim, 2005, A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model, J. Neurosci., 25, 3032, 10.1523/JNEUROSCI.4225-04.2005 · DOI
  70. Haass, 1992, Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments, Nature, 357, 500, 10.1038/357500a0 · DOI
  71. Westermark, 1973, Fine structure of islets of Langerhans in insular amyloidosis, Virchows Arch., A Pathol. Pathol. Anat., 359, 1, 10.1007/BF00549079 · DOI
  72. Westermark, 1987, Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells, Proc. Natl. Acad. Sci. U. S. A., 84, 3881, 10.1073/pnas.84.11.3881 · DOI · Paper page
  73. Woods, 2006, Pancreatic signals controlling food intake; insulin, glucagon and amylin, Philos. Trans. R. Soc. Lond., B. Biol. Sci., 361, 1219, 10.1098/rstb.2006.1858 · DOI
  74. Arora, 2006, Role of neuropeptides in appetite regulation and obesity — a review, Neuropeptides, 40, 375, 10.1016/j.npep.2006.07.001 · DOI
  75. Betsholtz, 1989, Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains differences in islet amyloid formation between species, FEBS Lett., 251, 261, 10.1016/0014-5793(89)81467-X · DOI
  76. Hoppener, 1999, Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model, Diabetologia, 42, 427, 10.1007/s001250051175 · DOI · Paper page
  77. Porat, 2003, The human islet amyloid polypeptide forms transient membrane-active prefibrillar assemblies, Biochemistry, 42, 10971, 10.1021/bi034889i · DOI
  78. Green, 2004, Human amylin oligomer growth and fibril elongation define two distinct phases in amyloid formation, J. Biol. Chem., 279, 12206, 10.1074/jbc.M312452200 · DOI
  79. Mirzabekov, 1996, Pore formation by the cytotoxic islet amyloid peptide amylin, J. Biol. Chem., 271, 1988, 10.1074/jbc.271.4.1988 · DOI
  80. Anguiano, 2002, Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes, Biochemistry, 41, 11338, 10.1021/bi020314u · DOI
  81. Kayed, 2004, Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases, J. Biol. Chem., 279, 46363, 10.1074/jbc.C400260200 · DOI
  82. Meier, 2006, Inhibition of human IAPP fibril formation does not prevent beta-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP, Am. J. Physiol., Endocrinol. Metab., 291, E1317, 10.1152/ajpendo.00082.2006 · DOI
  83. Huang, 2007, High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes, Diabetes, 56, 2016, 10.2337/db07-0197 · DOI
  84. Selkoe, 2000, Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein, Ann. N.Y. Acad. Sci., 924, 17, 10.1111/j.1749-6632.2000.tb05554.x · DOI
  85. Kelly, 1998, The environmental dependency of protein folding best explains prion and amyloid diseases, Proc. Natl. Acad. Sci. U. S. A., 95, 930, 10.1073/pnas.95.3.930 · DOI
  86. Dobson, 2001, The structural basis of protein folding and its links with human disease, Philos. Trans. R. Soc. Lond., B. Biol. Sci., 356, 133, 10.1098/rstb.2000.0758 · DOI
  87. Brownlee, 1995, Advanced protein glycosylation in diabetes and aging, Annu. Rev. Med., 46, 223, 10.1146/annurev.med.46.1.223 · DOI · Paper page
  88. Nogueira-Machado, 2008, From hyperglycemia to AGE-RAGE interaction on the cell surface: a dangerous metabolic route for diabetic patients, Expert Opin. Ther. Targets, 12, 871, 10.1517/14728222.12.7.871 · DOI
  89. Small, 2006, Sorting through the cell biology of Alzheimer's disease: Intracellular pathways to pathogenesis, Neuron, 52, 15, 10.1016/j.neuron.2006.09.001 · DOI
  90. Smith, 1995, Amyloidosis, advanced glycation end products and Alzheimer disease, NeuroReport, 6, 1595, 10.1097/00001756-199508000-00001 · DOI
  91. Smith, 1995, Radical AGEing in Alzheimer's disease, Trends Neurosci., 18, 172, 10.1016/0166-2236(95)93897-7 · DOI
  92. Smith, 1995, Early AGEing and Alzheimer's, Nature, 374, 316, 10.1038/374316b0 · DOI
  93. Hammes, 1995, Aminoguanidine does not inhibit the initial phase of experimental diabetic retinopathy in rats, Diabetologia, 38, 269, 10.1007/BF00400629 · DOI
  94. Knecht, 1992, Detection of 3-deoxyfructose and 3-deoxyglucosone in human urine and plasma: evidence for intermediate stages of the Maillard reaction in vivo, Arch. Biochem. Biophys., 294, 130, 10.1016/0003-9861(92)90146-N · DOI
  95. Mitsuhashi, 1993, Immunochemical detection of advanced glycation end products in renal cortex from STZ-induced diabetic rat, Diabetes, 42, 826, 10.2337/diab.42.6.826 · DOI
  96. Nakayama, 1993, Immunochemical detection of advanced glycation end products in lens crystallins from streptozocin-induced diabetic rat, Diabetes, 42, 345, 10.2337/diab.42.2.345 · DOI
  97. Munch, 1998, Alzheimer's disease–synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts, J. Neural Transm., 105, 439, 10.1007/s007020050069 · DOI
  98. Schmidt, 1996, RAGE: a novel cellular receptor for advanced glycation end products, Diabetes, 45, S77, 10.2337/diab.45.3.S77 · DOI
  99. Bierhaus, 2001, Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB, Diabetes, 50, 2792, 10.2337/diabetes.50.12.2792 · DOI
  100. Munch, 1997, Advanced glycation endproducts in ageing and Alzheimer's disease, Brain Res. Brain Res. Rev., 23, 134, 10.1016/S0165-0173(96)00016-1 · DOI
  101. Reddy, 2002, Involvement of Maillard reactions in Alzheimer disease, Neurotox. Res., 4, 191, 10.1080/1029840290007321 · DOI
  102. Vitek, 1994, Advanced glycation end products contribute to amyloidosis in Alzheimer disease, Proc. Natl. Acad. Sci. U. S. A., 91, 4766, 10.1073/pnas.91.11.4766 · DOI · Paper page
  103. Chen, 2004, Posttranslational modifications of tau–role in human tauopathies and modeling in transgenic animals, Curr. Drug Targets, 5, 503, 10.2174/1389450043345236 · DOI
  104. Necula, 2004, Pseudophosphorylation and glycation of tau protein enhance but do not trigger fibrillization in vitro, J. Biol. Chem., 279, 49694, 10.1074/jbc.M405527200 · DOI
  105. Smith, 1995, Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease, J. Neurochem., 64, 2660, 10.1046/j.1471-4159.1995.64062660.x · DOI
  106. Ko, 1999, An immunochemical study on tau glycation in paired helical filaments, Brain Res., 830, 301, 10.1016/S0006-8993(99)01415-8 · DOI
  107. Li, 1995, Age-dependent accumulation of advanced glycosylation end products in human neurons, Neurobiol. Aging, 16, 69, 10.1016/0197-4580(95)80009-G · DOI
  108. Shuvaev, 2001, Increased protein glycation in cerebrospinal fluid of Alzheimer's disease, Neurobiol. Aging, 22, 397, 10.1016/S0197-4580(00)00253-0 · DOI
  109. Smith, 1996, Quantitative solubilization and analysis of insoluble paired helical filaments from Alzheimer disease, Brain Res., 717, 99, 10.1016/0006-8993(95)01473-X · DOI
  110. Chaney, 2005, RAGE and amyloid beta interactions: atomic force microscopy and molecular modeling, Biochim. Biophys. Acta, 1741, 199, 10.1016/j.bbadis.2005.03.014 · DOI
  111. Du, 1997, Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease, Proc. Natl. Acad. Sci. U. S. A., 94, 5296, 10.1073/pnas.94.10.5296 · DOI
  112. Arancio, 2004, RAGE potentiates Abeta-induced perturbation of neuronal function in transgenic mice, EMBO J., 23, 4096, 10.1038/sj.emboj.7600415 · DOI
  113. Lue, 2001, Modeling microglial activation in Alzheimer's disease with human postmortem microglial cultures, Neurobiol. Aging, 22, 945, 10.1016/S0197-4580(01)00311-6 · DOI
  114. Lue, 2001, Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism, Exp. Neurol., 171, 29, 10.1006/exnr.2001.7732 · DOI · Paper page
  115. Moreira, 2005, Oxidative stress and neurodegeneration, Ann. N.Y. Acad. Sci., 1043, 545, 10.1196/annals.1333.062 · DOI
  116. Yan, 1998, RAGE-Abeta interactions in the pathophysiology of Alzheimer's disease, Restor. Neurol. Neurosci., 12, 167
  117. Origlia, 2008, Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction, J. Neurosci., 28, 3521, 10.1523/JNEUROSCI.0204-08.2008 · DOI
  118. Havrankova, 1978, Insulin receptors are widely but unevenly distributed in central nervous-system of rat, Clin. Res., 26, A491
  119. Havrankova, 1978, Insulin receptors are widely distributed in central nervous-system of rat, Nature, 272, 827, 10.1038/272827a0 · DOI
  120. Marks, 1990, Localization of insulin-receptor messenger-RNA in rat–brain by insitu hybridization, Endocrinology, 127, 3234, 10.1210/endo-127-6-3234 · DOI · Paper page
  121. Zhao, 1999, Brain insulin receptors and spatial memory — correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats, J. Biol. Chem., 274, 34893, 10.1074/jbc.274.49.34893 · DOI
  122. Werther, 1987, Localization and characterization of insulin-receptors in rat–brain and pituitary-gland using invitro autoradiography and computerized densitometry, Endocrinology, 121, 1562, 10.1210/endo-121-4-1562 · DOI
  123. Shemer, 1989, Insulin and IGF-I stimulate phosphorylation of their respective receptors in intact neuronal and glial cells in primary culture, J. Mol. Neurosci., 1, 3, 10.1007/BF02918899 · DOI
  124. Young, 1986, Periventricular hypothalamic cells in the rat–brain contain insulin messenger-RNA, Neuropeptides, 8, 93, 10.1016/0143-4179(86)90035-1 · DOI
  125. Clarke, 1986, Insulin is released from rat–brain neuronal cells in culture, J. Neurochem., 47, 831, 10.1111/j.1471-4159.1986.tb00686.x · DOI
  126. Wei, 1990, Release of immunoreactive insulin from rat–brain synaptosomes under depolarizing conditions, J. Neurochem., 54, 1661, 10.1111/j.1471-4159.1990.tb01219.x · DOI
  127. Devaskar, 1994, Insulin gene-expression and insulin synthesis in mammalian neuronal cells, J. Biol. Chem., 269, 8445, 10.1016/S0021-9258(17)37214-9 · DOI
  128. Schechter, 1996, Preproinsulin I and II mRNAs and insulin electron microscopic immunoreaction are present within the rat fetal nervous system, Brain Res., 736, 16, 10.1016/0006-8993(96)00664-6 · DOI
  129. Wozniak, 1993, The cellular and physiological actions of insulin in the central-nervous-system, Neurochem. Int., 22, 1, 10.1016/0197-0186(93)90062-A · DOI
  130. Heidenreich, 1985, Structural and functional-characteristics of insulin-receptors in rat neuro-blastoma cells, J. Neurochem., 45, 1642, 10.1111/j.1471-4159.1985.tb07237.x · DOI
  131. Raizada, 1988, Insulin-receptors in the brain — structural and physiological characterization, Neurochem. Res., 13, 297, 10.1007/BF00972477 · DOI
  132. Seino, 1989, Alternative splicing of human insulin-receptor messenger-RNA, Biochem. Biophys. Res. Commun., 159, 312, 10.1016/0006-291X(89)92439-X · DOI
  133. Goldstein, 1990, The rat insulin-receptor — primary structure and conservation of tissue-specific alternative messenger-RNA splicing, Mol. Endocrinol., 4, 235, 10.1210/mend-4-2-235 · DOI
  134. Goldstein, 1992, Heterogeneity of messenger-RNA that encodes the rat insulin-receptor is limited to the domain of exon 11 — analysis by RNA heteroduplex mapping, amplification of CDNA, and invitro translation, Diabetes, 41, 1293, 10.2337/diab.41.10.1293 · DOI
  135. Kenner, 1995, CDNA sequence-analysis of the human brain insulin-receptor, Biochem. Biophys. Res. Commun., 217, 304, 10.1006/bbrc.1995.2778 · DOI
  136. Huang, 1994, Hyperinsulinemia is associated with altered insulin-receptor messenger-RNA splicing in muscle of the spontaneously obese-diabetic rhesus-monkey, J. Clin. Invest., 94, 1289, 10.1172/JCI117447 · DOI
  137. Sbraccia, 1996, Chronic primary hyperinsulinaemia is associated with altered insulin receptor mRNA splicing in muscle of patients with insulinoma, Diabetologia, 39, 220, 10.1007/BF00403966 · DOI
  138. Schubert, 2004, Role for neuronal insulin resistance in neurodegenerative diseases, Proc. Natl. Acad. Sci. U. S. A., 101, 3100, 10.1073/pnas.0308724101 · DOI
  139. Zhao, 2004, Insulin and the insulin receptor in experimental models of learning and memory, Eur. J. Pharmacol., 490, 71, 10.1016/j.ejphar.2004.02.045 · DOI
  140. van der Heide, 2006, Insulin signaling in the central nervous system: Learning to survive, Prog. Neurobiol., 79, 205, 10.1016/j.pneurobio.2006.06.003 · DOI · Paper page
  141. Woods, 1978, The central nervous system, pancreatic hormones, feeding, and obesity, Adv. Metab. Disord., 9, 283, 10.1016/B978-0-12-027309-6.50020-3 · DOI
  142. Woods, 1985, Importance of the brain insulin system to food-intake, Appetite, 6, 216
  143. Baskin, 1987, Insulin in the brain, Ann. Rev. Physiol., 49, 335, 10.1146/annurev.ph.49.030187.002003 · DOI
  144. Bruning, 2000, Brain-specific disruption of the insulin receptor gene in mice results in obesity, hyperinsulinemia and dyslipidemia, Diabetes, 49, A279
  145. Woods, 2000, Food intake and the regulation of body weight, Ann. Rev. Psychol., 51, 255, 10.1146/annurev.psych.51.1.255 · DOI
  146. Schwartz, 2000, Central nervous system control of food intake, Nature, 404, 661, 10.1038/35007534 · DOI · Paper page
  147. Plum, 2005, The role of insulin receptor signaling in the brain, Trends Endocrinol. Metab., 16, 59, 10.1016/j.tem.2005.01.008 · DOI · Paper page
  148. Fehm, 2006, The selfish brain: competition for energy resources, Hypothal. Integr. Energy Metab., 153, 129
  149. Gerozissis, 2004, Brain insulin and feeding: a bi-directional communication, Eur. J. Pharmacol., 490, 59, 10.1016/j.ejphar.2004.02.044 · DOI
  150. Gerozissis, 2008, Brain insulin, energy and glucose homeostasis; genes, environment and metabolic pathologies, Eur. J. Pharmacol., 585, 38, 10.1016/j.ejphar.2008.01.050 · DOI
  151. Rotte, 2005, Insulin affects the neuronal response in the medial temporal lobe in humans, Neuroendocrinology, 81, 49, 10.1159/000084874 · DOI
  152. Eichenbaum, 2004, Hippocampus: cognitive processes and neural representations that underlie declarative memory, Neuron, 44, 109, 10.1016/j.neuron.2004.08.028 · DOI
  153. Kern, 1999, Central nervous system effects of intranasally administered insulin during euglycemia in men, Diabetes, 48, 557, 10.2337/diabetes.48.3.557 · DOI
  154. Kern, 1999, Effects of insulin on neurophysiological and behavioural measures of cognitive function in healthy humans, Diabetes, 48, A438
  155. Kern, 2001, Improving influence of insulin on cognitive functions in humans, Neuroendocrinology, 74, 270, 10.1159/000054694 · DOI · Paper page
  156. Park, 2000, Intracerebroventricular insulin enhances memory in a passive-avoidance task, Physiol. Behav., 68, 509, 10.1016/S0031-9384(99)00220-6 · DOI
  157. Benedict, 2007, Intranasal insulin to improve memory function in humans, Neuroendocrinology, 86, 136, 10.1159/000106378 · DOI
  158. Stockhorst, 2004, Insulin and the CNS: effects on food intake, memory, and endocrine parameters and the role of intranasal insulin administration in humans, Physiol. Behav., 83, 47, 10.1016/j.physbeh.2004.07.022 · DOI
  159. Reger, 2008, Intranasal insulin improves cognition and modulates beta-amyloid in early AD, Neurology, 70, 440, 10.1212/01.WNL.0000265401.62434.36 · DOI · Paper page
  160. Reger, 2008, Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults, J. Alzheimer’s Dis., 13, 323, 10.3233/JAD-2008-13309 · DOI
  161. Tomioka, 2006, The insulin/PI 3-kinase pathway regulates salt chemotaxis learning in Caenorhabditis elegans, Neuron, 51, 613, 10.1016/j.neuron.2006.07.024 · DOI
  162. Artola, 1993, Long-term depression of excitatory synaptic transmission and its relationship to long-term potentiation, Trends Neurosci., 16, 480, 10.1016/0166-2236(93)90081-V · DOI
  163. Zhuo, 1995, Long-term depression: a learning-related type of synaptic plasticity in the mammalian central nervous system, Rev. Neurosci., 6, 259, 10.1515/REVNEURO.1995.6.3.259 · DOI
  164. Biessels, 1998, Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment, Brain Res., 800, 125, 10.1016/S0006-8993(98)00510-1 · DOI
  165. Di Luca, 1999, NMDA receptor subunits are modified transcriptionally and post-translationally in the brain of streptozotocin-diabetic rats, Diabetologia, 42, 693, 10.1007/s001250051217 · DOI
  166. Lisman, 2006, A unified model of the presynaptic and postsynaptic changes during LTP at CA1 synapses, Sci. STKE., 2006, re11, 10.1126/stke.3562006re11 · DOI · Paper page
  167. Lisman, 2007, The sequence of events that underlie quantal transmission at central glutamatergic synapses, Nat. Rev. Neurosci., 8, 597, 10.1038/nrn2191 · DOI
  168. Bredt, 2003, AMPA receptor trafficking at excitatory synapses, Neuron, 40, 361, 10.1016/S0896-6273(03)00640-8 · DOI · Paper page
  169. Man, 2000, Intracellular trafficking of AMPA receptors in synaptic plasticity, Cell. Mol. Life Sci., 57, 1526, 10.1007/PL00000637 · DOI
  170. Wang, 2000, Expression of cerebellar long-term depression requires postsynaptic clathrin-mediated endocytosis, Neuron, 25, 635, 10.1016/S0896-6273(00)81066-1 · DOI
  171. Wang, 2008, Probing the role of AMPAR endocytosis and long-term depression in behavioural sensitization: relevance to treatment of brain disorders, including drug addiction, Br. J. Pharmacol., 153, S389, 10.1038/sj.bjp.0707616 · DOI
  172. Man, 2000, Regulation of AMPA receptor-mediated synaptic transmission by clathrin-dependent receptor internalization, Neuron, 25, 649, 10.1016/S0896-6273(00)81067-3 · DOI
  173. Lin, 2000, Distinct molecular mechanisms and divergent endocytotic pathways of AMPA receptor internalization, Nat. Neurosci., 3, 1282, 10.1038/81814 · DOI
  174. Zhou, 2001, Contribution of cytoskeleton to the internalization of AMPA receptors, Proc. Natl. Acad. Sci. U. S. A., 98, 1261, 10.1073/pnas.98.3.1261 · DOI
  175. Dalton, 2008, Disruption of AMPA receptor endocytosis impairs the extinction, but not acquisition of learned fear, Neuropsychopharmacology, 33, 2416, 10.1038/sj.npp.1301642 · DOI
  176. van der Heide, 2005, Insulin modulates hippocampal activity-dependent synaptic plasticity in a N-methyl-D-aspartate receptor and phosphatidyl-inositol-3-kinase-dependent manner, J. Neurochem., 94, 1158, 10.1111/j.1471-4159.2005.03269.x · DOI · Paper page
  177. Chiu, 2008, Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo, Neuron, 58, 708, 10.1016/j.neuron.2008.04.014 · DOI · Paper page
  178. Wan, 1997, Recruitment of functional GABA(A) receptors to postsynaptic domains by insulin, Nature, 388, 686, 10.1038/41792 · DOI
  179. Ma, 2003, Muscarinic potentiation of GABA(A) receptor currents is gated by insulin signaling in the prefrontal cortex, J. Neurosci., 23, 1159, 10.1523/JNEUROSCI.23-04-01159.2003 · DOI · Paper page
  180. Vetiska, 2007, GABA(A) receptor-associated phosphoinositide 3-kinase is required for insulin-induced recruitment of postsynaptic GABA(A) receptors, Neuropharmacology, 52, 146, 10.1016/j.neuropharm.2006.06.023 · DOI
  181. Caraiscos, 2007, Insulin increases the potency of glycine at ionotropic glycine receptors, Mol. Pharmacol., 71, 1277, 10.1124/mol.106.033563 · DOI
  182. Lynch, 2004, Molecular structure and function of the glycine receptor chloride channel, Physiol. Rev., 84, 1051, 10.1152/physrev.00042.2003 · DOI
  183. Seely, 1995, A functional assessment of insulin insulin-like growth-factor-i hybrid receptors, Endocrinology, 136, 1635, 10.1210/endo.136.4.7895674 · DOI
  184. Li, 2002, Hippocampal neuronal apoptosis in type 1 diabetes, Brain Res., 946, 221, 10.1016/S0006-8993(02)02887-1 · DOI
  185. Kasuga, 1982, Insulin stimulation of phosphorylation of the beta-subunit of the insulin-receptor — formation of both phosphoserine and phosphotyrosine, J. Biol. Chem., 257, 9891, 10.1016/S0021-9258(18)33955-3 · DOI
  186. Kahn, 1993, Molecular determinants of insulin action, Horm. Res., 39, 93, 10.1159/000182793 · DOI
  187. Khan, 2002, Insulin regulation of glucose uptake: a complex interplay of intracellular signalling pathways, Diabetologia, 45, 1475, 10.1007/s00125-002-0974-7 · DOI · Paper page
  188. Girard, 1994, Regulation of lipogenic enzyme gene-expression by nutrients and hormones, FASEB J., 8, 36, 10.1096/fasebj.8.1.7905448 · DOI
  189. Byon, 1998, Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction, Mol. Cell. Biochem., 182, 101, 10.1023/A:1006868409841 · DOI
  190. Kennedy, 2000, Protein tyrosine phosphatase-1B in diabetes, Biochem. Pharmacol., 60, 877, 10.1016/S0006-2952(00)00305-1 · DOI
  191. Czech, 1985, The nature and regulation of the insulin-receptor — structure and function, Ann. Rev. Physiol., 47, 357, 10.1146/annurev.ph.47.030185.002041 · DOI
  192. Zachayus, 1994, Protein-kinase-c and insulin-receptor beta-subunit serine phosphorylation in cultured fetal-rat hepatocytes, Mol. Cell. Endocrinol., 105, 11, 10.1016/0303-7207(94)90030-2 · DOI
  193. Mothe, 1996, Phosphorylation of insulin receptor substrate-1 on multiple serine residues, 612, 632, 662, and 731, modulates insulin action, J. Biol. Chem., 271, 11222, 10.1074/jbc.271.19.11222 · DOI
  194. EldarFinkelman, 1997, Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action, Proc. Natl. Acad. Sci. U. S. A., 94, 9660, 10.1073/pnas.94.18.9660 · DOI · Paper page
  195. Strack, 2000, Serine residues 994 and 1023/25 are important for insulin receptor kinase inhibition by protein kinase C isoforms beta 2 and theta, Diabetologia, 43, 443, 10.1007/s001250051327 · DOI
  196. Saltiel, 2002, Insulin signaling pathways in time and space, Trends Cell Biol., 12, 65, 10.1016/S0962-8924(01)02207-3 · DOI
  197. Morisco, 2005, Akt mediates the cross-talk between beta-adrenergic and insulin receptors in neonatal cardiomyocytes, Circ. Res., 96, 180, 10.1161/01.RES.0000152968.71868.c3 · DOI
  198. Draznin, 2006, Molecular mechanisms of insulin resistance: Serine phosphorylation of insulin receptor substrate-1 and increased expression of p85 alpha — The two sides of a coin, Diabetes, 55, 2392, 10.2337/db06-0391 · DOI
  199. Youngren, 2007, Regulation of insulin receptor function, Cell. Mol. Life Sci., 64, 873, 10.1007/s00018-007-6359-9 · DOI
  200. Takayama, 1984, Phorbol esters modulate insulin receptor phosphorylation and insulin action in cultured hepatoma cells, Proc. Natl. Acad. Sci. U. S. A., 81, 7797, 10.1073/pnas.81.24.7797 · DOI

200 of 308 shown

Cited by

Sorted by citations

Metadata

Authors
Zhao, W.-Q., & Townsend, M.
Venue
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Publisher
Elsevier BV
Published
2009-05
Volume
1792
Issue
5
Pages
482-496
ISSN
0925-4439
DOI
10.1016/j.bbadis.2008.10.014
Cited by
291
References
43
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review